A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
主要作者: | Shehab, Habibul Mohsin |
---|---|
其他作者: | Yasmin, Hasina |
格式: | Thesis |
語言: | English |
出版: |
Brac University
2024
|
主題: | |
在線閱讀: | http://hdl.handle.net/10361/22683 |
相似書籍
-
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
由: Tabassum, Nadira
出版: (2024) -
Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
由: Mahee, Sadique Abdal
出版: (2024) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
由: Alim, Abdul
出版: (2023) -
Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
由: Karmaker, Swastika
出版: (2024) -
A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
由: Jahan, Nusrat
出版: (2023)